Here are three notes:
1. The total transaction was valued at $770,000, at an average stock price per share of $22.
2. The highest price target for the stock is $26 and the lowest is $19.
3. The company has a market cap of $32.87 billion.
More articles on GI/endoscopy:
NY State Assemblyman introduces Upper Endoscopy Reform Act: 3 things to know
Certain mouth bacteria could help predict pancreatic cancer risk: 3 notes
Gastroenterologist Dr. Brian Levatino named 2016 Health Care Hero: 3 points
